Fatal Epstein-Barr virus-associated lymphoproliferative disorder following treatment with a novel mTOR Inhibitor for relapsed chronic lymphocytic leukemia

MLA

Katharina S. Götze, et al. “Fatal Epstein-Barr Virus-Associated Lymphoproliferative Disorder Following Treatment with a Novel MTOR Inhibitor for Relapsed Chronic Lymphocytic Leukemia.” Haematologica, vol. 92, no. 9, Sept. 2007. EBSCOhost, https://doi.org/10.3324/haematol.11155.

APA

Katharina S. Götze, Dieter Hoffmann, Hermann M. Schätzl, Christian Peschel, Falko Fend, & Thomas Decker. (2007). Fatal Epstein-Barr virus-associated lymphoproliferative disorder following treatment with a novel mTOR Inhibitor for relapsed chronic lymphocytic leukemia. Haematologica, 92(9). https://doi.org/10.3324/haematol.11155

Chicago

Katharina S. Götze, Dieter Hoffmann, Hermann M. Schätzl, Christian Peschel, Falko Fend, and Thomas Decker. 2007. “Fatal Epstein-Barr Virus-Associated Lymphoproliferative Disorder Following Treatment with a Novel MTOR Inhibitor for Relapsed Chronic Lymphocytic Leukemia.” Haematologica 92 (9). doi:10.3324/haematol.11155.